Transcatheter Embolization and Occlusion Devices – Market Insights – Europe (Supplemental)

COVID-19 has negatively impacted the European transcatheter embolization and occlusion device market, but the impact of COVID-19 is limited and short term, the market will expand at a moderate rate over the forecast period due to various driving factors such as growing adoption of minimally invasive treatment option such as embolization, increasing product launches, and adoption of advanced TEO devices supported by favorable clinical trial results.

This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for TEO devices in Europe from 2019 through 2032.

Table of contents